CABVEST — Caban Equity Investments Ltd
Strategic minority investments in scalable South African businesses — sourced through embedded advisory relationships, supported by an operating platform, exited by listing or trade sale.
Why advisory-driven dealflow matters
Most investors meet a business at the pitch. CABVEST meets businesses inside working advisory relationships — corporate finance engagements through the Caban Group — which means the diligence starts with operating reality rather than a deck. That embedded insight mitigates downside, sharpens valuation discipline, and produces a pipeline of vetted, scalable companies unavailable to broader investors.
The investment approach
- Disciplined valuation — forward PE, discounted cash flow and net asset value methodologies applied consistently, with multi-layered assessment before commitment.
- Active partnership — operational and strategic support alongside management teams, compounding value through hands-on governance rather than passive holding.
- Impact with integrity — investments that deliver financial returns and positive community impact, aligned with South Africa’s development goals.
- Planned exits — value realised through stock exchange listings or strategic trade sales, typically within five to seven years.
The operating platform behind the portfolio
Portfolio companies plug into shared group capability: corporate finance advisory for transactions, an in-house accounting function for financial control and compliance, an integrated digital marketing capability, independent valuation oversight, transparent investor reporting, and a group-wide risk management framework. Small and mid-sized businesses gain infrastructure they could not build alone — which is where the scaling happens.
The portfolio
The current portfolio spans water technology, bio-refining, construction materials, manufacturing and signage, business and accounting services, digital marketing, education and technology infrastructure — acquired at holdings ranging from strategic minority positions to full ownership. Company-level detail, holdings and engagement history are set out in the investor overview, available on request.
Leadership
Dave Romero (Group CEO), Ben Botes (Group MD) and Matthew Musgrove (Chief Operating Officer) lead execution, with a non-executive board bringing governance, risk, healthcare, property and technical depth: Lizelle van der Klashorst, Mapula Fisha, Mahomed Aslam and Prof Anthony Turton.
Documentation
The company overview — including portfolio detail, structure and current terms for qualifying investors — is available on request via the form on this page.
This page is provided for information purposes only and does not constitute an offer to the public of any securities in any jurisdiction, nor financial advice as defined in applicable legislation. Investment in unlisted securities involves risk, including the loss of capital, and there is no guarantee of returns. Prospective investors should obtain independent professional advice before making any investment decision. Company information and documentation are available to qualifying investors on request and govern in all respects.